RE:RE:RE:Strong technical analysisRayzzer,
Thank you for the link...I see where the first 3 were scheduled to be followed monthly for the first 3 months, then again at 6 months which appears to be a bit more screening than the trial design, but certainly makes for more effective following of their progress.
As for the "phenomenal" quote, I caution that this was/is the good doctor's personal comment, as he clearly states...earlier it was noted that there is a 30% bar set by the FDA which any trial needs to eclipse, so 2 of 9 would be somewhat less than phenomenal to the FDA, and 3 of 9 would be just clearing the FDA bar.
macman and/or LaserStock29,
I now see the source, but I've learned the hard way not to read too much into what is not clearly written...will the results for the first 3 at 6 mos.be published, or will they be held in abeyance for later viewing (e.g., when the results for the 6 are formally reviewed)...Ph1b is under way, so these results are not gating items for proceeding with the trial, but may be for the company's interest and for completeness only.